- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Ski-interacting protein (SNW1) is a multifunctional regulatory protein involved in transcriptional control, intracellular signaling, and RNA processing pathways. SKIP Antibody / Transcriptional Coregulator Protein is suitable for investigating signaling-dependent gene regulation, transcriptional coactivator complexes, and cellular regulatory mechanisms linked to proliferation and differentiation. The SKIP protein belongs to the SNW domain-containing protein family and participates in multiple signaling-associated transcriptional programs that coordinate cellular responses to extracellular and intracellular stimuli.
SKIP antibody, also referred to as SNW1 antibody, Ski interacting protein antibody, and SNW domain containing 1 antibody in the literature, recognizes a regulatory factor originally identified through interactions with the Ski oncogenic protein family. SKIP functions as a transcriptional coregulator that associates with nuclear receptor signaling complexes, transcriptional machinery, and RNA processing proteins. The protein has been linked to TGF-beta, Notch, vitamin D receptor, and steroid hormone signaling pathways, where it contributes to transcriptional modulation and coordinated gene expression responses.
Although SKIP is commonly associated with nuclear regulatory activity, studies have demonstrated both nuclear and cytoplasmic localization depending on cellular context and signaling conditions. This dynamic intracellular distribution is thought to reflect the protein's participation in signaling-responsive regulatory complexes and RNA-associated protein assemblies. SKIP has also been reported to associate with spliceosome-related components, supporting functional connections between transcriptional activation and RNA maturation processes.
Aberrant regulation of transcriptional coregulators such as SKIP can contribute to oncogenic signaling, altered differentiation programs, and abnormal cellular proliferation. Increased SNW1 expression has been described in several malignancies, including breast cancer, colorectal cancer, and hepatocellular carcinoma, where dysregulated transcriptional signaling and RNA processing pathways support tumor progression. Because SKIP participates in multiple regulatory pathways simultaneously, it has become relevant in studies examining pathway crosstalk, signaling integration, and adaptive gene expression mechanisms in cancer biology.
SKIP additionally contributes to developmental and differentiation-associated signaling programs. Functional studies suggest roles in embryogenesis, tissue patterning, and lineage specification through modulation of transcriptional networks responsive to extracellular signaling cues. The ability of SKIP to interact with multiple regulatory complexes positions this protein as an important signaling-responsive transcriptional adaptor in both normal physiology and disease-associated cellular remodeling.
Flow cytometry analysis of human HeLa cells with clone PCRP-SNW1-1C12 demonstrates detectable endogenous SKIP expression in cultured epithelial cells. An antibody targeting SKIP can therefore support investigations involving transcriptional coregulator proteins, signaling-responsive gene regulation, RNA-associated regulatory pathways, and cancer-related transcriptional adaptation mechanisms.
Explore our SNW1 Antibody / Transcription and RNA Splicing Factor Antibody page to learn more about this multifunctional regulatory protein involved in signaling-dependent transcription, RNA splicing, and intracellular gene expression control.
Optimal dilution of the SKIP Antibody / Transcriptional Coregulator Protein should be determined by the researcher.
A recombinant fragment of human protein was used as the immunogen for the SKIP antibody.
Aliquot the SKIP antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
SKIP antibody, Ski-interacting protein antibody, SNW1 antibody, SNW domain containing 1 antibody, NCoA-62 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.